Turn Therapeutics (TTRX) Enterprise Value (2024 - 2026)

Turn Therapeutics' Enterprise Value history runs 3 years deep, the most recent figure standing at -$11.2 million for Q1 2026.

• On a quarterly basis, Enterprise Value changed N/A year-over-year to -$11.2 million in Q1 2026; TTM through Mar 2026 was -$11.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$5.1 million, down 918.72% from the prior year.
• Enterprise Value eased to -$11.2 million in Q1 2026 per TTRX's latest filing, from -$5.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$498286.0 in Q3 2024 and bottomed at -$11.2 million in Q1 2026.
• The 3-year median for Enterprise Value is -$3.1 million (2025), against an average of -$4.1 million.
• Biggest YoY gain for Enterprise Value was 523.37% in 2025; the steepest drop was 918.72% in 2025.
• Year by year, Enterprise Value stood at -$498286.0 in 2024, then slumped by 918.72% to -$5.1 million in 2025, then slumped by 120.64% to -$11.2 million in 2026.
• Per Business Quant, the three latest TTRX Enterprise Value figures stand at -$11.2 million (Q1 2026), -$5.1 million (Q4 2025), and -$3.1 million (Q3 2025).